Drug General Information
Drug ID	D0S7TM
Former ID	DNC014389
Drug Name	2,2'-bi(1,3,4-thiadiazole)-5,5'(4H,4'H)-dithione
Drug Type	Small molecular drug
Indication	Discovery agent		Investigative	[530900]
Structure		Download 2D MOL 3D MOL
Formula	C4H2N4S4
Canonical SMILES	C1(=NNC(=S)S1)C2=NNC(=S)S2
InChI	1S/C4H2N4S4/c9-3-7-5-1(11-3)2-6-8-4(10)12-2/h(H,7,9)(H,8,10)
InChIKey	DAHNZAVSTBXUBS-UHFFFAOYSA-N
PubChem Compound ID	21790441
Target and Pathway
Target(s)	Tyrosine oxidase	Target Info	Inhibitor	[530900]
BioCyc Pathway	(S)-reticuline biosynthesis
	Eumelanin biosynthesis
	L-dopachrome biosynthesis
KEGG Pathway	Tyrosine metabolism
	Riboflavin metabolism
	Metabolic pathways
	Melanogenesis
PathWhiz Pathway	Riboflavin Metabolism
	Tyrosine Metabolism
WikiPathways	Dopamine metabolism
References
Ref 530900	Bioorg Med Chem. 2010 Jun 1;18(11):4042-8. Epub 2010 Apr 13.New potent inhibitors of tyrosinase: novel clues to binding of 1,3,4-thiadiazole-2(3H)-thiones, 1,3,4-oxadiazole-2(3H)-thiones, 4-amino-1,2,4-triazole-5(4H)-thiones, and substituted hydrazides to the dicopper active site.
Ref 530900	Bioorg Med Chem. 2010 Jun 1;18(11):4042-8. Epub 2010 Apr 13.New potent inhibitors of tyrosinase: novel clues to binding of 1,3,4-thiadiazole-2(3H)-thiones, 1,3,4-oxadiazole-2(3H)-thiones, 4-amino-1,2,4-triazole-5(4H)-thiones, and substituted hydrazides to the dicopper active site.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.